bioRxiv · 10.1101/2023.08.31.555720
Pathological mutations reveal the key role of the iRhom2 N-terminus for ADAM17 binding, stability and activity.
Abstract
The protease ADAM17 plays an important role in inflammation and cancer and is regulated by iRhom2. Mutations in the cytosolic N-terminus of human iRhom2 cause tylosis with oesophageal cancer (TOC). In mice, partial deletion of the N-terminus results in a curly hair phenotype (cub). These pathological consequences are consistent with our findings that iRhom2 is highly expressed in keratinocytes and in oesophageal cancer. Cub and TOC are associated with hyperactivation of ADAM17-dependent EGFR signalling. However, the underlying molecular mechanisms are not understood. We have identified a non-canonical, phosphorylation-independent 14-3-3 interaction site that encompasses all known TOC mutations. Disruption of this site dysregulates ADAM17 activity. The larger cub deletion also includes the TOC site and thus also dysregulated ADAM17 activity. The cub deletion, but not the TOC mutation, also causes severe reductions in stimulated shedding, binding, and stability of ADAM17, demonstrating the presence of additional regulatory sites in the N-terminus of iRhom2. Overall, this study contrasts the TOC and cub mutations, illustrates their different molecular consequences, and reveals important key functions of the iRhom2 N-terminus in regulating ADAM17.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Bläsius, K., Ludwig, L., Knapp, S., Flasshove, C., Sonnabend, F., Keller, D., Tacken, N., Gao, X., Kahveci, S., Grannemann, C., Babendreyer, A., Adrain, C., Huth, S., Baron, J., Ludwig, A., Düsterhöft, S.. 2023-09-01. Pathological mutations reveal the key role of the iRhom2 N-terminus for ADAM17 binding, stability and activity.. https://doi.org/10.1101/2023.08.31.555720
Cite the original work for its findings. Save a collection to share your selection of sources.